EP Wealth Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$379K Buy
750
+106
+16% +$54.8K ﹤0.01% 1121
2026
Q2
$300K Sell
644
-41
-6% -$17.2K ﹤0.01% 1296
2026
Q1
$259K Sell
685
-369
-35% -$158K ﹤0.01% 1252
2025
Q4
$451K Buy
+1,054
New +$459K ﹤0.01% 933
2025
Q2
$579K Sell
1,190
-8
-0.7% -$4.56K ﹤0.01% 729
2025
Q1
$737K Sell
1,198
-117
-9% -$66.5K 0.01% 576
2024
Q4
$697K Sell
1,315
-39
-3% -$22K 0.01% 592
2024
Q3
$814K Buy
1,354
+25
+2% +$14.2K 0.01% 547
2024
Q2
$721K Sell
1,329
-130
-9% -$74.5K 0.01% 454
2024
Q1
$937K Sell
1,459
-428
-23% -$260K 0.01% 389
2023
Q4
$1.1M Buy
1,887
+57
+3% +$31.9K 0.01% 352
2023
Q3
$951K Sell
1,830
-13,670
-88% -$7.11M 0.01% 337
2023
Q2
$989K Buy
15,500
+8,148
+111% +$4.45M 0.01% 339
2023
Q1
$650K Buy
7,352
+5,461
+289% +$2.78M 0.01% 364
2022
Q4
$965K Buy
+1,891
New +$920K 0.02% 287

Other funds holding CHE

EP Wealth Advisors's CHE Position: Q3 2026 in Review

EP Wealth Advisors increased its Chemed (CHE) stake by 16% in Q3 2026, buying an estimated $54.8K and bringing the position to 750 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

EP Wealth Advisors first reported a position in CHE in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.1M in Q4 2023. 544 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • EP Wealth Advisors held 750 shares of Chemed worth $379K as of Q3 2026.
  • EP Wealth Advisors bought 106 Chemed shares in Q3 2026, an estimated $54.8K.
  • Chemed made up ﹤0.01% of EP Wealth Advisors's portfolio in Q3 2026, its #1121 holding.
  • EP Wealth Advisors first reported a position in Chemed in Q4 2022 and has held it in 15 quarters since.
  • EP Wealth Advisors's Chemed position peaked at $1.1M in Q4 2023.
  • 544 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on EP Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.